CVE
Price
$28.39
Change
-$2.35 (-7.64%)
Updated
Nov 4 closing price
Capitalization
52.36B
96 days until earnings call
Intraday BUY SELL Signals
XOM
Price
$169.27
Change
-$8.19 (-4.62%)
Updated
Nov 4 closing price
Capitalization
696.02B
89 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CVE vs XOM

CVE vs XOM Comparison Chart in %
View a ticker or compare two or three
A.I.Advisor
Nov 02, 2026

Which Stock Would AI Choose? Cenovus Energy (CVE) vs. Exxon Mobil (XOM) Stock Comparison

Key Takeaways

  • Cenovus Energy has posted record upstream production and accelerating earnings growth, supported by the recent MEG Energy acquisition, while Exxon Mobil offers unmatched scale, a fortress balance sheet, and 43 consecutive years of dividend growth.
  • Cenovus Energy has shown stronger recent price momentum and more favorable earnings revisions, whereas Exxon Mobil is trading near all-time highs despite declining full-year earnings.
  • The two companies operate on very different scales: Exxon Mobil is a global supermajor producing roughly 4.7 million oil-equivalent barrels per day, while Cenovus Energy is a Canadian integrated producer with around 900,000 barrels of oil equivalent per day.
  • Tickeron AI Verdict: On balance, Tickeron's AI would currently favor CVE for its stronger relative momentum, improving earnings trajectory, and the MEG integration catalyst, while acknowledging XOM's superior stability and scale.
  • For more context, explore CVE Major News and CVE Today's Price Move, as well as XOM Major News and XOM Today's Price Move.
  • To see how algorithmic strategies are positioning across the market, browse the curated Trending AI Robots.

Introduction

Energy investors weighing Canadian integrated producers against global supermajors frequently compare CVE and XOM. Cenovus Energy is a Calgary-based integrated energy company focused on oil sands, conventional production, and refining, while Exxon Mobil is one of the world's largest publicly traded energy corporations with diversified operations spanning upstream, downstream, and chemicals. This stock comparison is relevant for traders assessing relative momentum, as well as for longer-term investors evaluating balance-sheet quality, dividend durability, and growth catalysts. Although both companies operate in the same commodity environment, their market positioning, scale, and recent performance have diverged in meaningful ways, making a head-to-head review useful for understanding where each stands in the current energy cycle.

CVE Overview and Recent Performance

CVE, or Cenovus Energy, is a Canadian integrated oil and natural gas company with significant oil sands assets, conventional production in the Western Canadian Sedimentary Basin, offshore interests, and refining operations in Canada and the United States. Recent market activity has favored the stock, which has outperformed the broader oils-energy sector over the past year and drawn multiple analyst upgrades and Buy ratings. The company's full-year 2025 results showed record upstream production of roughly 918,000 barrels of oil equivalent per day in the fourth quarter, with full-year net earnings rising year over year.

A defining recent development was the completion of the C$7.6 billion acquisition of MEG Energy, which expanded Cenovus's oil sands portfolio and is expected to generate meaningful synergies in the coming years. Management has also renewed a share-repurchase program allowing buybacks of up to 10% of the public float. These catalysts, combined with improving cost performance, have supported positive sentiment and momentum in the stock.

XOM Overview and Recent Performance

XOM, or Exxon Mobil, is a U.S.-based energy supermajor with integrated operations across upstream production, refining, and chemicals. Recent market activity reflects a focus on "advantaged" assets in the Permian Basin and offshore Guyana, where record production helped the company offset lower crude prices. Full-year 2025 output averaged about 4.7 million oil-equivalent barrels per day, the highest in more than four decades.

Despite operational strength, Exxon Mobil's full-year 2025 earnings declined from the prior year as weaker crude prices and chemical margins weighed on results. The company returned roughly $37 billion to shareholders through dividends and buybacks, raised its dividend by 4%, and extended its streak of annual dividend-per-share growth to 43 consecutive years. With a net-debt-to-capital ratio near 11% and a market capitalization approaching $600 billion, Exxon Mobil remains a benchmark of scale and financial stability, though its shares now trade at elevated valuation multiples relative to recent history.

Trending AI Robots

For traders seeking a data-driven edge, Tickeron's Trending AI Robots page offers a curated view of algorithmic trading strategies. Tickeron hosts hundreds of AI trading bots that collectively monitor thousands of different tickers, each with its own trading style, timeframe, strategy, and performance record. Because market conditions change, only the bots best suited to the current environment earn a place in this curated section, helping users filter through a broad universe of automated strategies. Whether you are evaluating a single stock comparison like this one or managing a diversified watchlist, exploring the Trending AI Robots page can provide additional context on how algorithmic systems are interpreting current trends and positioning across the market.

Head-to-Head Comparison

The core contrast between CVE and XOM is one of scale versus momentum. Exxon Mobil's diversified, global asset base and low-cost Permian and Guyana projects give it resilient cash generation and a peer-leading balance sheet, but its earnings are more exposed to broad commodity cycles and its valuation has risen as the stock approached record highs. Cenovus Energy, by contrast, is more concentrated in Canadian oil sands and refining, which makes it more sensitive to Western Canadian crude differentials and refining crack spreads, but also positions it to benefit directly from a focused MEG-led growth strategy.

On growth drivers, Exxon Mobil leans on advantaged volume growth and structural cost savings, while Cenovus emphasizes oil sands optimization and acquisition synergies. On risk factors, Cenovus carries a higher relative debt load following the MEG transaction, whereas Exxon Mobil maintains an industry-leading, low-leverage profile. Market sentiment has been comparatively more positive for Cenovus in recent weeks, reflected in analyst upgrades and stronger momentum, while Exxon Mobil's stability appeals more to income-focused and defensive investors.

Tickeron AI Verdict

Based on observable factors such as trend consistency, earnings trajectory, relative momentum, and near-term catalysts, Tickeron's AI would likely lean toward CVE in the current environment. Cenovus Energy's improving production, rising earnings, analyst upgrades, and the MEG integration synergies present a clearer momentum-and-catalyst profile than Exxon Mobil's stability-heavy but earnings-declining setup. That said, this is a probabilistic read rather than a definitive one; Exxon Mobil's superior scale, balance-sheet strength, and dividend track record remain significant advantages, particularly for investors prioritizing capital preservation and income. The AI's preference for CVE reflects a momentum-oriented weighting that could shift as market conditions evolve.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

VS
CVE vs. XOM commentary
Nov 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVE is a Hold and XOM is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CVE with price predictions
Nov 04, 2026

CVE in downward trend: price dove below 50-day moving average on November 02, 2026

CVE moved below its 50-day moving average on November 02, 2026 date and that indicates a change from an upward trend to a downward trend. In 31 of 42 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 74%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CVE as a result. In 59 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 64%.

The Moving Average Convergence Divergence Histogram (MACD) for CVE turned negative on October 27, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 32 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 64%.

The 10-day moving average for CVE crossed bearishly below the 50-day moving average on November 04, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 69%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for CVE's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +3.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where CVE advanced for three days, in 271 of 354 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

CVE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 237 of 291 cases where CVE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 81%.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 36 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 29, placing this stock slightly worse than average.

The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. CVE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.531) is normal, around the industry mean (1.615). P/E Ratio (7.886) is within average values for comparable stocks, (10.939). Projected Growth (PEG Ratio) (0.110) is also within normal values, averaging (1.088). Dividend Yield (0.022) settles around the average of (0.049) among similar stocks. P/S Ratio (1.435) is also within normal values, averaging (3.764).

The Tickeron PE Growth Rating for this company is 85 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
a Summary for XOM with price predictions
Nov 04, 2026

XOM's RSI Oscillator recovers from overbought zone

The 10-day RSI Oscillator for XOM moved out of overbought territory on November 02, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 instances where the indicator moved out of the overbought zone. In 26 of the 41 cases the stock moved lower in the days that followed. This puts the odds of a move down at 63%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on XOM as a result. In 43 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 46%.

The Moving Average Convergence Divergence Histogram (MACD) for XOM turned negative on November 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 21 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 41%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XOM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 44%.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a +2.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where XOM advanced for three days, in 232 of 371 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.

XOM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 192 of 312 cases where XOM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 5 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 29, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 9 (best 1 - 100 worst), indicating outstanding price growth. XOM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: XOM's P/B Ratio (2.683) is slightly higher than the industry average of (1.615). XOM has a moderately high P/E Ratio (21.785) as compared to the industry average of (10.939). Projected Growth (PEG Ratio) (1.392) is also within normal values, averaging (1.088). Dividend Yield (0.024) settles around the average of (0.049) among similar stocks. P/S Ratio (1.911) is also within normal values, averaging (3.764).

FUNDAMENTALS RATINGS
CVE vs XOM: Fundamental Ratings
CVE
XOM
OUTLOOK RATING
1..100
7236
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
86
Overvalued
PROFIT vs RISK RATING
1..100
365
SMR RATING
1..100
4562
PRICE GROWTH RATING
1..100
419
P/E GROWTH RATING
1..100
8514
SEASONALITY SCORE
1..100
8575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CVE's Valuation (48) in the Oil And Gas Production industry is somewhat better than the same rating for XOM (86) in the Integrated Oil industry. This means that CVE’s stock grew somewhat faster than XOM’s over the last 12 months.

XOM's Profit vs Risk Rating (5) in the Integrated Oil industry is in the same range as CVE (36) in the Oil And Gas Production industry. This means that XOM’s stock grew similarly to CVE’s over the last 12 months.

CVE's SMR Rating (45) in the Oil And Gas Production industry is in the same range as XOM (62) in the Integrated Oil industry. This means that CVE’s stock grew similarly to XOM’s over the last 12 months.

XOM's Price Growth Rating (9) in the Integrated Oil industry is in the same range as CVE (41) in the Oil And Gas Production industry. This means that XOM’s stock grew similarly to CVE’s over the last 12 months.

XOM's P/E Growth Rating (14) in the Integrated Oil industry is significantly better than the same rating for CVE (85) in the Oil And Gas Production industry. This means that XOM’s stock grew significantly faster than CVE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CVEXOM
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
63%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
73%
Momentum
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
46%
MACD
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
41%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
43%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 1 day ago
64%
Advances
ODDS (%)
Bullish Trend 11 days ago
77%
Bullish Trend 7 days ago
63%
Declines
ODDS (%)
Bearish Trend 15 days ago
66%
Bearish Trend 1 day ago
44%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
75%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
62%
COMPARISON
Comparison
Nov 05, 2026
Stock price -- (CVE: $28.39 vs. XOM: $169.27)
Brand notoriety: CVE: Not notable vs. XOM: Notable
Both companies represent the Integrated Oil industry
Current volume relative to the 65-day Moving Average: CVE: 164% vs. XOM: 187%
Market capitalization -- CVE: $52.36B vs. XOM: $696.02B
CVE [@Integrated Oil] is valued at $52.36B. XOM’s [@Integrated Oil] market capitalization is $696.02B. The market cap for tickers in the [@Integrated Oil] industry ranges from $63.2K to $696.02B. The average market capitalization across the [@Integrated Oil] industry is $133.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVE’s FA Score shows that 0 FA rating(s) are green while XOM’s FA Score has 3 green FA rating(s).

  • CVE’s FA Score: 0 green, 5 red.
  • XOM’s FA Score: 3 green, 2 red.
According to our system of comparison, CVE is a better buy in the long-term than XOM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVE’s TA Score shows that 5 TA indicator(s) are bullish while XOM’s TA Score has 4 bullish TA indicator(s).

  • CVE’s TA Score: 5 bullish, 5 bearish.
  • XOM’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, XOM is a better buy in the short-term than CVE.

Price Growth

CVE (@Integrated Oil) experienced а -12.08% price change this week, while XOM (@Integrated Oil) price change was -7.00% for the same time period.

The average weekly price growth across all stocks in the @Integrated Oil industry was -8.40%. For the same industry, the average monthly price growth was -4.79%, and the average quarterly price growth was +2.66%.

Reported Earning Dates

CVE is expected to report earnings on Feb 09, 2027.

XOM is expected to report earnings on Feb 02, 2027.

Industries' Descriptions

@Integrated Oil (-8.40% weekly)

Integrated oil companies are involved across nearly the entire oil value chain – from upstream operations like exploration and production, to downstream functions of refining and marketing. Exxon Mobil Corporation, Chevron Corporation and BP are major integrated oil companies. Their bottom lines’ response to crude oil prices could depend on the proportion of upstream vs. downstream businesses; for example, if a company has substantial downstream business, the adverse impact on their upstream business due to falling crude prices could be mitigated by benefits to its downstream business.

View a ticker or compare two or three
Interact to see
Advertisement

XOM and

Correlation & Price change

A.I.dvisor indicates that over the last year, XOM has been closely correlated with CVX. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if XOM jumps, then CVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOM
1D Price
Change %
XOM100%
-4.62%
CVX - XOM
83%
Closely correlated
-3.69%
EQNR - XOM
75%
Closely correlated
-6.20%
BP - XOM
73%
Closely correlated
-4.16%
CVE - XOM
70%
Closely correlated
-7.64%
SHEL - XOM
69%
Closely correlated
-2.25%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GRPN17.311.81
+11.68%
Groupon
FSLY21.03-0.03
-0.17%
Fastly
TPST0.46-0.01
-1.13%
Tempest Therapeutics Inc
TARA2.35-0.06
-2.49%
Protara Therapeutics
ENTG142.87-9.89
-6.47%
Entegris